Publication date: May 14, 2026
The purpose of this research study is to test if the combination of three drugs, valacyclovir, celecoxib, and Paxlovid will decrease the symptoms of Long COVID in adults compared to a placebo (this does not contain the medications).
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Long COVID |
| drug | DRUGBANK | Valaciclovir |
| drug | DRUGBANK | Celecoxib |
| drug | DRUGBANK | Metamfetamine |
| drug | DRUGBANK | Cocaine |
| drug | DRUGBANK | Phencyclidine |
| disease | MESH | psychiatric disorder |
| disease | MESH | anxiety |
| disease | MESH | obsessive-compulsive disorder |
| disease | MESH | alcohol use disorder |
| disease | MESH | substance use disorder |
| drug | DRUGBANK | Medical Cannabis |
| disease | MESH | bipolar disorder |
| disease | MESH | schizophrenia |
| disease | MESH | schizoaffective disorder |
| disease | MESH | cardiac |
| disease | MESH | hepatitis |
| disease | MESH | bacterial infection |
| drug | DRUGBANK | Prednisone |
| drug | DRUGBANK | Warfarin |
| drug | DRUGBANK | Heparin |
| drug | DRUGBANK | Digoxin |
| drug | DRUGBANK | Amiodarone |
| drug | DRUGBANK | Isoniazid |
| drug | DRUGBANK | Phenytoin |
| drug | DRUGBANK | Fluconazole |
| drug | DRUGBANK | Methotrexate |
| drug | DRUGBANK | Probenecid |
| drug | DRUGBANK | Raloxifene |
| disease | MESH | sleep apnea |
| disease | MESH | weight loss |
| disease | MESH | IBS |
| disease | MESH | colonic inertia |
Original Article
(Visited 3 times, 1 visits today)